AZTR
Companies
Nyse American
Azitra Inc.
Health Care
$0.25
Price Chart
Overview
About AZTR
azitra, inc. is a preclinical stage biotechnology company harnessing the power of the microbiome to treat skin disease. the company was founded in 2014 by scientists from yale university and works with world-leading scientists in dermatology, microbiology, and genetic engineering to advance its programs in atopic dermatitis and targeted orphan indications. for more information visit www.azitrainc.com.
Market Cap
$4.3M
Volume
76.8K
Avg. Volume
84.5K
P/E Ratio
-0.54269236
Dividend Yield
0.00%
Employees
12.0
Company Information
Latest News for AZTR
Risk & Correlation Analysis
Market Correlation
N/A
N/A
Volatility
N/A
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
High Sensitivity
GDP Growth
High Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, AZTR shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Pricing info last updated June 19, 2025 (after market close)Other info last updated April 2, 2025